| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BioAtla, Inc. | Director | Common Stock | 52.3K | $22.5K | $0.43 | Jun 18, 2025 | Direct |
| RayzeBio, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 0 | $0 | $62.50 | Feb 26, 2024 | Direct |
| Tyra Biosciences, Inc. | Director | Stock Option (Right to Buy) | 22.2K | May 29, 2025 | Direct | ||
| CRESCENT BIOPHARMA, INC. | Director | Stock Option (Right to Buy) | 9.02K | Jun 23, 2025 | Direct | ||
| RayzeBio, Inc. | CHIEF MEDICAL OFFICER | Employee Stock Option (right to buy) | 0 | Feb 26, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CBIO | GLYCOMIMETICS INC | Jun 23, 2025 | 1 | $0 | 4 | Jun 23, 2025 | Director |
| BCAB | BioAtla, Inc. | Jun 18, 2025 | 1 | $0 | 4 | Jun 18, 2025 | Director |
| CBIO | GLYCOMIMETICS INC | Jun 13, 2025 | 0 | $0 | 3 | Jun 23, 2025 | Director |
| TYRA | Tyra Biosciences, Inc. | May 29, 2025 | 1 | $0 | 4 | Jun 2, 2025 | Director |
| BCAB | BioAtla, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| TYRA | Tyra Biosciences, Inc. | May 7, 2024 | 1 | $0 | 4 | May 9, 2024 | Director |
| TYRA | Tyra Biosciences, Inc. | May 7, 2024 | 0 | $0 | 3 | May 9, 2024 | Director |
| RYZB | RayzeBio, Inc. | Feb 26, 2024 | 5 | -$20.2M | 4 | Feb 27, 2024 | CHIEF MEDICAL OFFICER |
| RYZB | RayzeBio, Inc. | Jan 22, 2024 | 2 | $100K | 4 | Feb 6, 2024 | CHIEF MEDICAL OFFICER |
| RYZB | RayzeBio, Inc. | Nov 17, 2023 | 1 | $0 | 4 | Nov 17, 2023 | Chief Medical Officer |
| RYZB | RayzeBio, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Chief Medical Officer |
| BCAB | BioAtla, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| BCAB | BioAtla, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| BCAB | BioAtla, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |